Afuco™ Anti-Human IL21R ADCC Therapeutic Antibody (PF-05230900), ADCC Enhanced

Anti-IL21R ADCC Enhanced Antibody (PF-05230900) is an ADCC enhanced antibody produced by our Afuco™ platform. PF-05230900 is a fully human monoclonal anti-IL-21 receptor (IL-21R) antibody, has a prolonged PD effect measured by IL-21R occupancy; was highly immunogenic after single dose administration and has PK properties with rapid clearance and low bioavailability.
Supplier Creative Biolabs
Product # AFC-399CL
Pricing Inquiry
Host Human
Target IL21R
Species Reactivity Human
Type ADCC enhanced antibody
Storage 4°C or -20°C, avoid repeated freezing and thawing.
Feedback